FDC Limited and Rising Pharmaceuticals, Inc. have recalled 382,104 units of Timolol Maleate Ophthalmic Solution (USP, 0.5%) because of a defect in the packaging. A yellow-colored spike from the cap can become lodged in the nozzle of the bottle, which was discovered after several customers reported the issue. The recall affects both 5mL and 15mL prescription eye drop bottles distributed in New Jersey.
The plastic spike lodged in the nozzle can prevent the medication from being dispensed correctly or may fall into the user's eye during application, potentially causing physical injury or interfering with the treatment of eye conditions.
You have 2 options:
Distributed by Rising Pharmaceuticals, Inc, NJ.
Distributed by Rising Pharmaceuticals, Inc, NJ.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.